CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 831 enrolled
Drug / intervention
Fixed site standard of care testing +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04673292
NCT04673292N/ACompleted

Community Collaboration to Combat COVID-19

Johns Hopkins University·interventional·Posted Dec 17, 2020·Updated Jul 8, 2024

In Brief

A clinical study evaluating Fixed site standard of care testing, Community-based, mobile van testing, and 1 other intervention for Coronavirus Infection. Completed, enrolled 831 participants across 1 site.

Detailed Summary

This is randomized trial where households will be randomized to identify the optimal SARS-CoV-2 (COVID-19) testing modality in a population-representative sample of households in Baltimore City, Maryland. 1,386 households in Baltimore City will be randomized 1:1:1 to one of three testing modalities: 1) fixed-site standard of care testing; 2) community-based mobile van testing; or 3) self-collected home, based testing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 17, 2020
Enrollment StartFeb 8, 2021
Primary CompletionJun 9, 2023
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 5.5 years ago

Interventions

Fixed site standard of care testingbehavioral

This arm includes all three Johns Hopkins (JHMI) ambulatory outdoor testing sites across Baltimore City. Each site represents a traditional appointment-based scheduling system. Participants will be given a choice of 1 of 3 outdoor testing locations based on their preferences. Study staff will make an appointment for testing based on testing availability and participant schedule.

Community-based, mobile van testingbehavioral

This arm offers the convenience of highly accessible testing and with the flexibility of no fixed appointment time. Each of the 12 geographic strata will have a single, centrally located testing site within the area, providing similar geographic access across households. The testing location will be published on the study website and social media so that participants can visit the location at a time convenient to them.

Self-collected, home-based testingbehavioral

Individuals will receive a home-based testing kit delivered by a courier service as soon as the randomization of the household is complete. The kit will include provisions for contacting the courier service for pick up. Appropriate biohazard precautions are included. Each of the testing components of this kit will include FDA Emergency Use Authorization approved collection methods. Easy to use instructions with options to view pre-recorded videos and/or virtual 'on demand' coaching sessions with members of the study team via a HIPAA-secure Zoom session will be available.